The latest ACQUITY™ and XBridge™ Premier 125Å SEC Columns from Waters Corporation address key challenges in biotherapeutic development by offering advanced capabilities for peptide and protein separations. Equipped with MaxPeak™ High Performance Surfaces (HPS), these columns simplify workflows while ensuring reliable results.
Benefits for lab managers:
- Faster Turnaround Times: Six times faster separation than standard SEC columns reduces analysis time.
- Improved Productivity: MaxPeak HPS technology eliminates pre-conditioning steps, streamlining lab operations.
- Consistency Across Labs: Rigorous batch-testing ensures reproducibility for large-scale biopharmaceutical projects.
- Enhanced Data Quality: Superior resolution and high molecular weight product (HMWP) recovery provide greater confidence in results.
- Seamless Integration: Compatible with existing UHPLC and HPLC systems, reducing the need for new investments.
Lab managers working in biotherapeutics can now achieve more consistent, high-quality data while optimizing their team’s workflow. These SEC columns are an indispensable tool for ensuring safety, efficacy, and regulatory compliance.
This article has been sourced from a press release and may include content created or refined using AI tools and verified by our editorial team. The press release was provided by Waters Corporation
